Behind the Scenes of the Spanish Biotech Industry’s Boom
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in…
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in…
Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells…
I sat down with Eduardo Bravo, CEO of TiGenix, to talk about the technology that…
Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead…
An EMA committee has supported an allogeneic stem cell therapy for the first time, as TiGenix's Crohn's…
TiGenix’s candidate for a nasty Crohn’s disease complication received orphan drug designation after agreeing on…
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
Before the “who to recruit” phase, an important question is “where?” We ran through the…
TiGenix announces positive one-year results for its phase I/II trial of donor-derived cardiac stem cell therapy in…
TiGenix has treated the first patient in a new early-stage clinical trial to test its…
TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this…
Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position…